Science
Survodutide: The GLP-1/Glucagon Dual Agonist
Boehringer Ingelheim enters the chat. This dual agonist targets both GLP-1 and Glucagon receptors for enhanced fat burning.
ByPeptide Bioregulator Atlas (Adapted)
April 17, 2024
Boehringer Ingelheim enters the chat. This dual agonist targets both GLP-1 and Glucagon receptors for enhanced fat burning.